Fulton Breakefield Broenniman’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $208K | Sell |
2,184
-120
| -5% | -$11.5K | 0.01% | 199 |
|
|
2026
Q1 | $239K | Sell |
2,304
-100
| -4% | -$11.3K | 0.02% | 175 |
|
|
2025
Q4 | $242K | Sell |
2,404
-275
| -10% | -$29.9K | 0.02% | 181 |
|
|
2025
Q3 | $330K | Sell |
2,679
-33
| -1% | -$4.1K | 0.02% | 151 |
|
|
2025
Q2 | $326K | Sell |
2,712
-345
| -11% | -$46K | 0.02% | 152 |
|
|
2025
Q1 | $450K | Sell |
3,057
-273
| -8% | -$41.7K | 0.03% | 119 |
|
|
2024
Q4 | $541K | Hold |
3,330
| – | – | 0.04% | 115 |
|
|
2024
Q3 | $542K | Sell |
3,330
-50
| -1% | -$7.41K | 0.04% | 112 |
|
|
2024
Q2 | $461K | Sell |
3,380
-146
| -4% | -$20.3K | 0.03% | 118 |
|
|
2024
Q1 | $540K | Sell |
3,526
-270
| -7% | -$40.3K | 0.04% | 107 |
|
|
2023
Q4 | $541K | Sell |
3,796
-210
| -5% | -$28K | 0.04% | 107 |
|
|
2023
Q3 | $525K | Sell |
4,006
-208
| -5% | -$31.6K | 0.05% | 104 |
|
|
2023
Q2 | $670K | Sell |
4,214
-92
| -2% | -$14.8K | 0.06% | 101 |
|
|
2023
Q1 | $681K | Sell |
4,306
-92,529
| -96% | -$13.9M | 0.06% | 102 |
|
|
2022
Q4 | $13.6M | Buy |
96,835
+501
| +0.5% | +$71.1K | 1.21% | 37 |
|
|
2022
Q3 | $12.4M | Sell |
96,334
-951
| -1% | -$137K | 1.16% | 35 |
|
|
2022
Q2 | $13.7M | Sell |
97,285
-830
| -0.8% | -$119K | 1.19% | 37 |
|
|
2022
Q1 | $13.6M | Buy |
98,115
+11,015
| +13% | +$1.69M | 1.2% | 33 |
|
|
2021
Q4 | $15.2M | Sell |
87,100
-713
| -0.8% | -$119K | 1.12% | 38 |
|
|
2021
Q3 | $14.5M | Buy |
87,813
+1,180
| +1% | +$203K | 1.25% | 35 |
|
|
2021
Q2 | $15.6M | Buy |
86,633
+3
| +0% | +$548 | 1.33% | 32 |
|
|
2021
Q1 | $16.7M | Buy |
86,630
+11,980
| +16% | +$2.31M | 1.55% | 27 |
|
|
2020
Q4 | $15.1M | Sell |
74,650
-10,511
| -12% | -$2.18M | 1.81% | 22 |
|
|
2020
Q3 | $17.9M | Sell |
85,161
-900
| -1% | -$200K | 2.02% | 18 |
|
|
2020
Q2 | $18.9M | Buy |
86,061
+1,010
| +1% | +$202K | 2.29% | 9 |
|
|
2020
Q1 | $14.7M | Sell |
85,051
-383
| -0.4% | -$63.3K | 2.2% | 12 |
|
|
2019
Q4 | $13.1M | Buy |
85,434
+595
| +0.7% | +$88.9K | 1.53% | 23 |
|
|
2019
Q3 | $12.9M | Buy |
84,839
+465
| +0.6% | +$73.5K | 1.64% | 22 |
|
|
2019
Q2 | $12.9M | Buy |
84,374
+806
| +1% | +$123K | 2.04% | 19 |
|
|
2019
Q1 | $13.4M | Sell |
83,568
-482
| -0.6% | -$74.8K | 2.18% | 13 |
|
|
2018
Q4 | $13M | Sell |
84,050
-1,353
| -2% | -$211K | 2.29% | 8 |
|
|
2018
Q3 | $12.8M | Sell |
85,403
-591
| -0.7% | -$84K | 2% | 14 |
|
|
2018
Q2 | $11.6M | Sell |
85,994
-953
| -1% | -$118K | 1.86% | 15 |
|
|
2018
Q1 | $11.6M | Sell |
86,947
-857
| -1% | -$115K | 2.01% | 12 |
|
|
2017
Q4 | $13.1M | Sell |
87,804
-269
| -0.3% | -$36.6K | 2.19% | 5 |
|
|
2017
Q3 | $11.6M | Sell |
88,073
-971
| -1% | -$130K | 2.02% | 8 |
|
|
2017
Q2 | $11.9M | Sell |
89,044
-154
| -0.2% | -$20.8K | 2.12% | 8 |
|
|
2017
Q1 | $12M | Sell |
89,198
-1,337
| -1% | -$173K | 2.23% | 4 |
|
|
2016
Q4 | $10.9M | Buy |
90,535
+12,632
| +16% | +$1.49M | 2.15% | 8 |
|
|
2016
Q3 | $9.75M | Sell |
77,903
-16
| -0% | -$2.1K | 1.98% | 12 |
|
|
2016
Q2 | $10.8M | Buy |
77,919
+619
| +0.8% | +$80.3K | 2.2% | 6 |
|
|
2016
Q1 | $9.74M | Buy |
77,300
+1,787
| +2% | +$227K | 2.13% | 7 |
|
|
2015
Q4 | $9.58M | Buy |
75,513
+1,760
| +2% | +$218K | 2.12% | 6 |
|
|
2015
Q3 | $8.52M | Sell |
73,753
-481
| -0.6% | -$54K | 2.01% | 8 |
|
|
2015
Q2 | $7.72M | Buy |
74,234
+2,338
| +3% | +$252K | 1.69% | 15 |
|
|
2015
Q1 | $7.94M | Buy |
71,896
+1,419
| +2% | +$154K | 1.77% | 15 |
|
|
2014
Q4 | $7.34M | Sell |
70,477
-50
| -0.1% | -$5K | 1.61% | 18 |
|
|
2014
Q3 | $6.77M | Sell |
70,527
-433
| -0.6% | -$39.2K | 1.59% | 16 |
|
|
2014
Q2 | $6.49M | Sell |
70,960
-1,560
| -2% | -$140K | 1.57% | 18 |
|
|
2014
Q1 | $6.38M | Sell |
72,520
-542
| -0.7% | -$47.6K | 1.65% | 19 |
|
|
2013
Q4 | $6.78M | Sell |
73,062
-1,857
| -2% | -$167K | 1.79% | 11 |
|
|
2013
Q3 | $6.12M | Buy |
74,919
+598
| +0.8% | +$50.5K | 1.65% | 17 |
|
|
2013
Q2 | $6.18M | Buy |
+74,321
| New | +$6.39M | 1.81% | 12 |
|
Other funds holding CLX
Fulton Breakefield Broenniman's CLX Position: Q2 2026 in Review
Fulton Breakefield Broenniman reduced its Clorox (CLX) stake by 5.2% in Q2 2026, selling an estimated $11.5K and leaving 2,184 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #199.
Fulton Breakefield Broenniman first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.9M in Q2 2020. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Fulton Breakefield Broenniman held 2,184 shares of Clorox worth $208K as of Q2 2026.
- Fulton Breakefield Broenniman sold 120 Clorox shares in Q2 2026, an estimated $11.5K.
- Clorox made up 0.01% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #199 holding.
- Fulton Breakefield Broenniman first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
- Fulton Breakefield Broenniman's Clorox position peaked at $18.9M in Q2 2020.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.